There are 2949 resources available
Current overview and how to select patients in first-line
Presenter: Jean-Pascal Machiels
Session: What other immunotherapy options are there in recurrent metastatic disease?
Resources:
Slides
Webcast
Beyond the use of checkpoint inhibitor
Presenter: Ezra Cohen
Session: What other immunotherapy options are there in recurrent metastatic disease?
Resources:
Slides
Webcast
Immunotherapy in NPC
Presenter: Brigette Ma
Session: What other immunotherapy options are there in recurrent metastatic disease?
Resources:
Slides
Webcast
Tumour micro-environmental and systemic barriers to T-cell immunotherapy
Presenter: Douglas Hanahan
Session: Tumour heterogeneity and its influence on cancer and immune therapy responses
Resources:
Slides
Webcast
Genomic determinants and tumour heterogeneity of checkpoint inhibitor response
Presenter: Nicholas McGranahan
Session: Tumour heterogeneity and its influence on cancer and immune therapy responses
Resources:
Slides
Webcast
Imaging and targeting premetastatic niches in melanoma
Presenter: Marisol Soengas
Session: Tumour heterogeneity and its influence on cancer and immune therapy responses
Resources:
Slides
Webcast
Intratumour heterogeneity and its influence on immune response
Presenter: Yardena Samuels
Session: Tumour heterogeneity and its influence on cancer and immune therapy responses
Resources:
Slides
Webcast
Update on the ICH GCP Renovation process
Presenter: Fergus Sweeney
Session: How to run clinical trials and survive your CRO
Resources:
Slides
Webcast
The implementation of the EU Clinical Trials Regulation: Let’s get it right
Presenter: Anastassia Negrouk
Session: How to run clinical trials and survive your CRO
Resources:
Webcast
Is good clinical practice becoming poor clinical care?
Presenter: Steven Le Gouill
Session: How to run clinical trials and survive your CRO
Resources:
Slides
Webcast